@article{van den Anker_2013, place={Quartu Sant’Elena (CA, Italy)}, title={Neonatal abstinence syndrome: a never ending story!}, volume={2}, url={https://jpnim.com/index.php/jpnim/article/view/020231}, DOI={10.7363/020231}, abstractNote={Neonatal Abstinence syndrome (NAS) is the result of fetal exposure to illicit or prescription drugs (for example opioids, benzodiazepines, and selective serotonin reuptake inhibitors) taken by the mother prenatally. NAS is a complex of symptoms, caused by acute withdrawal of the illicit drug(s) used by their mothers during pregnancy, seen in neonates hours or days after being born. In the United States of America around 16% of teenagers and 7% of women between the ages of 18 and 25 use illicit drugs during their pregnancies. In this paper the treatment<span lang="en-US"><strong> </strong></span><span lang="en-US">of opioid dependence during pregnancy and treatment of NAS are presented.<p> </p><p><strong>Proceedings of the 9<sup>th</sup> International Workshop on Neonatology · Cagliari (Italy) · October 23<sup>rd</sup>-26<sup>th</sup>, 2013 · <em>Learned lessons, changing practice and cutting-edge research</em></strong></p></span>}, number={2}, journal={Journal of Pediatric and Neonatal Individualized Medicine (JPNIM)}, author={van den Anker, Johannes N.}, year={2013}, month={Oct.}, pages={e020231} }